The correlation of osteoporosis to clinical features: A study of 4382 Female Cases of a Hospital Cohort with musculoskeletal symptoms in Southwest China

BMC Musculoskeletal Disorders

Volumn 11, Issue , 2010, Pages

  Li, Shasha ^a,b   He, Hongchen ^a,b   Ding, Mingfu ^a,b   He, Chengqi ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b Province Key Laboratory of Rehabilitation Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CHINA; CIGARETTE SMOKING; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FRACTURE; HUMAN; HYPEROSTOSIS; HYPERTENSION; LEG PAIN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MENOPAUSE; MORBIDITY; NECK PAIN; OSTEOPOROSIS; PARESTHESIA; PHYSICAL ACTIVITY; RISK FACTOR; SHOULDER PAIN; ASIAN; COHORT ANALYSIS; COMORBIDITY; ETHNOLOGY; HOSPITAL; MIDDLE AGED; MUSCULOSKELETAL DISEASE; OBESITY; PAIN; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; RETROSPECTIVE STUDY; SEDENTARY LIFESTYLE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; COMORBIDITY; FEMALE; HOSPITALS; HUMANS; MIDDLE AGED; MUSCULOSKELETAL DISEASES; OBESITY; OSTEOPOROSIS, POSTMENOPAUSAL; PAIN; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEDENTARY LIFESTYLE;

EID: 77955532239     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-11-183     Document Type: Article

References (40)

1. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Study Group, World Health Organization, Geneva 1994
2. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. George A Wells Ann Cranney Joan Peterson Michel Boucher Beverley Shea Vivian Welch Doug Coyle Peter Tugwell, Cochrane Database of Systematic Reviews 2008 1
3. Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. GA Wells A Cranney J Peterson M Boucher B Shea V Welch D Coyle P Tugwell, Cochrane Database of Systematic Reviews 2008 1
4. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. GA Wells A Cranney J Peterson M Boucher B Shea V Welch D Coyle P Tugwell, Cochrane Database of Systematic Reviews 2008 1
5. How many women have osteoporosis now? LJ Melton III, J Bone Miner Res 1995 10 2 175 177 10.1002/jbmr.5650100202 7754796
6. Diagnosis of osteoporosis and assessment of fracture risk. JA Kanis, Lancet 2002 359 9321 1929 1936 10.1016/S0140-6736(02)08761-5 12057569
7. Assessment of Osteoporosis at the Primary Care Level. P Bonjour P Clark C Cooper, et al. WHO Technical Report Series WHO, Geneva 2007
8. Epidemiological investigation of peak bone density and the incidence of osteoporosis in China. ZH Liu YL Zhao LN Lin, J Bone Miner Res 1997 12 Suppl 1 245
9. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. TW O'Neill D Felsenberg J Varlow C Cooper JA Kanis AJ Silman, J Bone Miner Res 1996 11 1010 1018 10.1002/jbmr.5650110719 8797123
10. Declaration of Helsinki: World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects, Bulletin of the World Health Organization 2001 79 4 373 374 11357217
11. Dual Emission x-Ray Absorptiometry (DEXA) Diagnostic Medical Systems. Revision 03, Date of Release: 09,09,1998. Challenger osteodensitometer - User Manual
12. Prevalence of low femoral bone density in older U.S. adults from NHANES III. AC Looker ES Orwoll CC Johnston Jr RL Lindsay HW Wahner WL Dunn MS Calvo TB Harris SP Heyse, J Bone Miner Res 1997 12 11 1761 1768 10.1359/jbmr.1997.12.11. 1761 9383679
13. Epidemiology of fractures in England and Wales. TP Van Staa EM Dennison HG Leufkens C Cooper, Bone 2001 29 6 517 522 10.1016/S8756-3282(01)00614-7 11728921
14. Osteoporosis in the older woman. SJ Andersen, Clin Obstet Gynecol 2007 50 3 752 766 10.1097/GRF.0b013e3180dba614 17762423
15. Structural model for osteoporosis preventing behavior in postmenopausal women. PJ Estok CA Sedlak MO Doheny R Hall, Nurs Res 2007 56 3 148 158 10.1097/01.NNR.0000270031.64810.0c 17495570
16. Pathogenesis of osteoporosis. RG Russell, Rheumatology Mosby, New York, Hochberg MC, Silman AJ, Smolen SJ, Weinblatt ME, Weisman MH, 2003 2075 2147
17. Bone biology and the pathogenesis of osteoporosis. RG Russell B Espina P Hulley, Curr Opin Rheumatol 2006 18 Suppl 1 3 S10 10.1097/01.bor.0000229521. 95384.7d 16735843
18. Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. O Johnell B Gullberg JA Kanis E Allander L Elffors J Dequeker G Dilsen C Gennari A Lopes Vaz G Lyritis, et al. J Bone Miner Res 1995 10 11 1802 1815 10.1002/jbmr.5650101125 8592959
19. Bone density at various sites for prediction of hip fractures: the Study of Osteoporotic Fractures Research Group. SR Cummings DM Black MC Nevitt W Browner J Cauley K Ensrud HK Genant L Palermo J Scott TM Vogt, Lancet 1993 341 8837 72 75 10.1016/0140-6736(93)92555-8 8093403
20. Role of estrogens in the management of postmenopausal bone loss. JC Gallagher, Rheum Dis Clin North Am 2001 27 1 143 162 10.1016/S0889-857X(05) 70191-5 11285992
21. Elderly African-American and Caucasian men are infrequently screened for osteoporosis. JS Richards HA Young R DeSagun GS Kerr, J Natl Med Assoc 2005 97 714 717 15926649
22. Clinical research on osteopathia. W He L Zhang W Wang E Gong, Science and Technology, Beijing 2006 323 335
23. Influence of educational level and marital status on dietary intake, obesity and other cardiovascular risk factors in a Hong Kong Chinese population. J Woo SS Leung SC Ho A Sham TH Lam ED Janus, Eur J Clin Nutr 1999 53 6 461 467 10.1038/sj.ejcn.1600777 10403582
24. Prevalence of osteoporosis by educational level in a cohort of postmenopausal women. M Varenna L Binelli F Zucchi D Ghiringhelli M Gallazzi L Sinigaglia, Osteoporos Int 1999 9 3 236 241 10.1007/s001980050143 10450413
25. Preventive health services use, lifestyle health behavior risks, and self-reported health status of women in Ohio by ethnicity and completed education status. L Guo A Short, Womens Health Issues 2002 12 2 96 102 10.1016/S1049-3867(01)00137-2 11879762
26. Patient education with reference to the process of behavioral change. H Basler, Patient Educ Couns 1995 26 1-3 93 98 10.1016/0738-3991(95)00724-E 7494761
27. Determinants of osteoporosis prevention in low-income Mexican-American women. CH Orces C Casas S Lee R Garci-Cavazos W White, South Med J 2003 96 5 458 464 10.1097/01.SMJ.0000051905.38128.B4 12911184
28. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. SC Ho JL Woo SS Leung AL Sham TH Lam ED Janus, J Nutr 2000 130 10 2590 2593 11015494
29. High habitual calcium intake attenuates bone loss in early postmenopausal Chinese women: an 18-month follow-up study. SC Ho YM Chen JLF Woo SS Lam, J Clin Endocrinol Metab 2004 89 5 2166 2170 10.1210/jc.2003-031338 15126537
30. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. JA Kanis CC Glüer, Osteoporos Int 2000 11 3 192 202 10.1007/s001980050281 10824234
31. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. D Marshall O Johnell H Wedel, BMJ 1996 312 7041 1254 1259 8634613
32. Population-based reference values for bone mineral density in young men. M Hoiberg TL Nielsen K Wraae B Abrahamsen C Hagen M Andersen K Brixen, Osteoporos Int 2007 18 11 1507 1514 10.1007/s00198-007-0399-8 17534538
33. Positive associations of bone mineral density with body mass index, physical activity, and blood triglyceride level in men over 70 years old: a TCVGHAGE study. YJ Tang WH Sheu PH Liu WJ Lee YT Chen, J Bone Miner Metab 2007 25 1 54 59 10.1007/s00774-006-0727-7 17187194
34. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men. EJ Rhee KW Oh WY Lee SW Kim ES Oh KH Baek MI Kang CY Park MG Choi HJ Yoo SW Park, J Bone Miner Metab 2004 22 4 392 398 10.1007/s00774-003-0500-0 15221500
35. FRAXand the assessment of fracture probability in men and women from the UK. JA Kanis O Johnell A Oden H Johansson E McCloskey, Osteoporos Int 2008 19 4 385 397 10.1007/s00198-007-0543-5 18292978
36. Case finding for the management of osteoporosis with FRAX -assessment and intervention thresholds for the UK. JA Kanis EV McCloskey H Johansson O Strom F Borgstrom A Oden National Osteoporosis Guideline Group, Osteoporos Int 2008 19 10 1395 1408 10.1007/s00198-008-0712-1 18751937
37. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). S Fujiwara T Nakamura H Orimo T Hosoi I Gorai A Oden H Johansson JA Kanis, Osteoporos Int 2008 19 4 429 435 10.1007/s00198-007-0544-4 18292977
38. Genetic determination and correlation of body mass index and bone mineral density at the spine and hip in Chinese Han ethnicity. FY Deng SF Lei MX Li C Jiang V Dvornyk HW Deng, Osteoporos Int 2006 17 1 119 124 10.1007/s00198-005- 1930-4 16025191
39. Beta3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). CY Wang N D Nguyen NA Morrison JA Eisman JR Center TV Nguyen, Bmc Med Genetics 2006 7 57 10.1186/1471-2350-7-57
40. A Bivariate Whole-Genome Linkage Scan Suggests Several Shared Genomic Regions for Obesity and Osteoporosis. ZH Tang P Xiao SF Lei FY Deng LJ Zhao HY Deng LJ Tan H Shen DH Xiong RR Recker HW Deng, J Clin Endocrinol Metab 2007 92 7 2751 2757 10.1210/jc.2006-2607 17473065